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Epilepsy remains a major medical problem of unknown aetiology. Potentially, viruses can be environmental
triggers for development of seizures in genetically vulnerable individuals. An estimated half of encephalitis
patientsexperienceseizuresand 4%developstatusepilepticus.Epilepsyvulnerabilityhasbeenassociatedwith
a dynorphin promoter region polymorphism or low dynorphin expression genotype, in man. In animals, the
dynorphin system in the hippocampus is known to regulate excitability. The present study was designed to test
the hypothesis that reduced dynorphin expression in the dentate gyrus of hippocampus due to periadolescent
virus exposure leads to epileptic responses. Encephalitis produced by the neurotropic Borna disease virus in the
rat caused epileptic responses and dynorphin to disappear via dentate granule cell loss, failed neurogenesis and
poor survival of new neurons. Kappa opioid (dynorphin) agonists prevented the behavioural and electroence-
phalographic seizuresproducedbyconvulsant compounds, andthese effectswere associated withan absenceof
dynorphin from the dentate gyrus granule cell layer and upregulation of enkephalin in CA1 interneurons, thus
reproducing a neurochemical marker of epilepsy, namely low dynorphin tone. A key role for kappa opioids in
anticonvulsant protection provides a framework for exploration of viral and other insults that increase seizure
vulnerability and may provide insights into potential interventions for treatment of epilepsy.
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Abbreviations: BDNF = brain derived neurotrophic factor; BDV = Borna disease virus; BrdU = bromodeoxyuridine;
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NLX = naloxone; nor-BNI = nor-binaltorphimine; NeuN = neuronal nuclei
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Introduction
Seizuresandstatusepilepticusincrease encephalitismorbidity
and mortality. Despite advances in diagnostic techniques, no
causal agent is identiﬁed in the majority of encephalitis cases
(Koskiniemi et al., 2001; Glaser et al., 2003), which limits
agent-speciﬁc therapies. The opioid system in the hippocam-
pus is known to regulate excitability (Henriksen et al., 1982;
Wagner et al., 1993; Weisskopf et al., 1993; Madamba et al.,
1999). Dynorphin distribution and regulation are consistent
with endogenous anticonvulsant function in experimental
models (Kanamatsu et al., 1986; Tortella, 1988; Gall et al.,
1990; Douglass et al., 1991; Hong et al., 1992; Romualdi et al.,
1995; Simonato and Romualdi, 1996; Pierce et al., 1999) and a
low dynorphin expression genotype in man is associated with
epilepsy vulnerability (Stogmann et al., 2002; Gambardella
et al., 2003). Recent hypotheses have also addressed the
role of dynorphin in viral seizures (Solbrig and Koob, 2004).
In man, Borna disease virus (BDV) has been associated
with hippocampal sclerosis (de la Torre et al., 1996;
Czygan et al., 1999) and neuropsychiatric disorders (Lipkin
et al., 2001; Ikuta et al., 2002). In rats, BDV causes a persistent
infection with time-based neurological sequelae (Narayan
et al., 1983; Solbrig et al., 1994), one of which has an epileptic
phenotype (Solbrig and Koob, 2004; Solbrig et al., 2005).
Given dynorphin expression can be an important deter-
minant of seizure vulnerability, we tested the hypothesis
that reduced dynorphin expression in the dentate gyrus
of hippocampus owing to periadolescent virus exposure
leads to epileptic responses. Using neuropharmacological,
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 anatomical, electrophysiological and biochemical/metabolic
techniques to study BDV-infected rats, we ﬁnd imbalance
in hippocampal opioid systems causes seizures and a kappa
opioid controls seizures. Besides illustrating viral pathways to
disease, the work provides a framework for exploration of
viral and other insults that increase seizure vulnerability.
Materials and methods
Animals
Subjects were male Lewis rats (Charles River Labs, Wilmington, MA,
USA) group housed on a 12 h light–dark cycle with ad libitum
access to food and water. All experimental procedures were
performed in compliance with institutional (University of
California-Irvine Institutional Animal Care and Use Committee;
Animal Welfare Assurance no. A3416-01) and National Institutes
of Health guidelines.
Infection of animals
Anaesthesia was induced with inhaled methoxyﬂurane administered
in a closed bell jar containing gauze soaked with anaesthetic to
achieve 0.22% minimal alveolar concentration (Committee on
Pain and Distress in Laboratory Animals, ILAR, 1992). Under
methoxyﬂurane anaesthesia, 4-week-old males were infected intra-
cerebrally with BDV (BD rats) by injection of 1.6 · 10
4 tissue culture
infectious dose units, strain He/80-1, or sham infected with sterile
phosphate buffered saline (PBS) (NL rats) (Solbrig et al., 1994).
Neuropharmacological testing was 6 weeks after infection (Solbrig
et al., 1994). Additional behavioural, morphological and histological
analyses were at different times after infection, as indicated.
Drugs
Drugs used were the general opioid antagonist naloxone (NLX)
(1 mg/kg s.c.) (Sigma, St Louis, MO, USA), the kappa opioid
receptor (KOR) agonist U-50488 (trans–(6)-3,4–dichloro-N-
methyl-N–[2-1(-pyrrolidinyl)cyclohexyl] benzeneacetamide) (10,
20, 40 mg/kg s.c.) (Sigma) (Tortella et al., 1986), morphine sulphate
(5 mg/kg s.c.) (NIDA, Bethesda, MD, USA), nor-binaltorphimine
(nor-BNI) (10 mg/kg s.c.) (Tocris, Ellisville, MO, USA) dissolved
in saline. Naloxone dose dependently produces seizures in BD rats
(Solbrig et al., 1996) and 1 mg/kg s.c. is always convulsant in
BD animals. A 10 mg/kg s.c. nor-BNI is a mid-range dose that
modiﬁes analgesic or hyperthermic responding (Endoh et al.,
1992). Morphine 5 mg/kg s.c. is an analgesic dose that initiates
the development of dependence (Britton et al., 1985; Schulteis
et al., 1997). U-50488 40 mg/kg s.c. is the lowest dose reported to
fully protect against supramaximal electroshock seizures (Tortella
et al., 1986).
Electroencephalography
BD and NL rats were anaesthetized with ketamine + xylazine
(87 mg/kg + 13 mg/kg, i.p.) (Western Medical Supply, Arcadia,
CA, USA). Stainless steel screw electrodes (Plastics One, Roanoke,
VA, USA) were implanted in the cranium over the right and left
retrosplenial cortices (overlaying hippocampus), ﬁxed to the skull
with dental cement. Ground electrodes were placed in the frontal
bones over the prefrontal cortex. EEG signals were recorded con-
tinuously for up to 3 h after injections of naloxone (1 mg/kg s.c.),
nor-BNI (10 mg/kg s.c.) and morphine (5 mg/kg s.c.). EEG signals
were obtained from unrestrained rats using commutators with
ﬂexible recording cables (Plastics One, Roanoke, VA, USA), and
ampliﬁed and displayed in a Grass Polygraph (Model P511) using
manufacturer’s settings, data acquisition (PolyVIEW/XL) and
analysis software (Astro-Med, Inc./Grass Telefactor, W. Warwick,
RI, USA). After surgery, animals were allowed to recover for
1 week before study. Seizures were characterized by rhythmic
spike or sharp wave discharges on the EEG tracings, with amplitudes
at least two times higher than baseline, and accompanied by
epileptic-like behaviours (staring spells, behaviour arrest, twitches,
chewing, wet dog shakes, clonus, rearing with loss of balance)
(Racine, 1972). Neuropharmacological experimental groups con-
tained 4–8 BD rats and age-matched controls. EEGs also were
recorded from younger animals where indicated.
Data analysis
Numbers of animals observed with epileptic behaviours were ana-
lysed using the Information Statistic for non-parametric indepen-
dent samples (Kullback, 1968). Observations of epileptic-like
behaviours were veriﬁed with recorded EEGs.
Histochemistry
The hippocampal formation was chosen for morphological study,
based on localization of seizures to hippocampal areas (Solbrig
et al., 2005) and tropism of virus to this region (Narayan et al.,
1983). Dynorphin and enkephalin immunoreactivity (IR) in hippo-
campal formation were examined 6 weeks after infection, processing
free-ﬂoating 50 mm frozen sections as described (Solbrig et al., 2005)
with primary antibodies to dynorphin A (1–17) (1:500, Serotec,
Oxford, UK) or met
5-enkephalin (1:500, Chemicon, Temecula,
CA, USA) (n = 4 per group, BD or NL). Antiserum against
dynorphin A(1–17) has <0.001% cross reactivity to Dyn A(1–8),
leu
5-enkephalin,a-neo-endorphin andDynB(1-13).Met
5-enkepha-
lin antibody has 5.8% cross reactivity to leu
5-enkephalin and <0.1%
to other endorphins.
Next, viral effects on dynorphin expression in hippocampal for-
mation were examined, measuring transcript levels in hippocampus
and tracking development and maturation of granule cells, the only
dynorphin-expressing cells of hippocampal formation.
Northern blot analyses
Effect of BDV infection on preprodynorphin (PPD) transcription in
hippocampus was examined by northern hybridization. An aliquot
of 15 mg total RNA from hippocampal tissue of BD rats 6 weeks after
infection, extracted in Tri-Reagent (Molecular Research Centre Inc,
Cincinnati, OH, USA) was size-fractionated in 2.2 M for-
maldehyde/1% agarose gels, transferred to nylon membranes, UV
crosslinked and hybridized to random primed
32PDNA fragments
generated from cloned DNA representing dynorphin sequence
(Civelli et al., 1985) with GAPD transcripts as control for RNA
loaded. Autoradiographic signals were quantiﬁed by phosphorima-
ging (Storm 840 Phosphorimager; Molecular Dynamics, Sunnyvale,
CA, USA) (n = 8 per group).
To measure viral effects on hippocampal cell proliferation, bro-
modeoxyuridine (BrdU) labelling was performed. To identify cell
types exhibiting BrdU or BDV immunostaining, double-label studies
were performed. To characterize viral effects on development of
neurochemical phenotype, double label studies were performed.
Kappa opioid control of viral seizures Brain (2006), 129, 642–654 643
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 BrdU injections
BrdU (Sigma) dissolved in saline was administered to rats at 5 weeks
of age (1 week after BD infection) at a dose of 50 mg/kg i.p. ·3
(3 times on day 0) to label dividing cells (Kuhn et al., 1996). To
evaluate the effect of BDV on cell proliferation, rats were sacriﬁced
the following day. To evaluate effects of BDV on survival of newly
born cells, rats were sacriﬁced 1, 2.5 or 4 weeks after last BrdU
injection (n = 4 per experimental group). Brains of all rats were
processed immunohistochemically for combined BrdU and markers
of several cell types using peroxidase or ﬂuorescent methods to assess
phenotype of newly born cells (Kuhn et al., 1996).
Histological procedures
Aone-in-sixseriesofsectionsfromcontrolandBDanimalssurviving
1 day, 1, 2.5 and 4 weeks after the injection of BrdU were processed
for BrdU (1:400 for DAB, Chemicon; 1:100 for ﬂuorescence, Accu-
rate, Westbury, NY, USA) and several cell type markers—neuronal
nuclei (NeuN) (1:1000, Chemicon) anti-NeuN for mature neurons,
glial ﬁbrillary acidic protein (GFAP) (1:2000, Dako, Glostrup,
Denmark) for astroglia, OX42 (1:500, Serotec) for microglia and
mouse monoclonal antibody (38/15 H76) against BDV nucleo-
protein (1:500, gift of L. Stitz). Other primary antibodies
used were dynorphin A (Serotec 1:500), met-enkephalin (1:500,
Chemicon), MASH1 (mammalian achaete-scute homologue)
(1:250, Chemicon) and doublecortin (DCX) (1:500, Chemicon).
BrdU labelling required the following pretreatment: DNA denatura-
tion (50% formamide in 2· SSC, 65
oC, 2 h), acidiﬁcation (2N HCl
37
oC, 30 min), rinse (0.1 M boric acid pH 8.5, 10 min) to reduce
reactive aldehydes, and membrane permeabilization (0.25% Triton,
3% normal horse serum in PBS, 1 h). Because of reports of BrdU
promotingneuronalapoptosis(Sekerkovaetal.,2004),histology was
evaluated in additional animals age matched to neuropharmacology
animal subjects. MASH1 labelling required wash in 0.3% H2O2 in
methanol for 15 min, PBS washes and overnight incubation in 6%
normal goat serum with 0.2% Tween-20. Other antibodies used
incubations in 3% NGS and 0.2% Triton X-100, except dynorphin
A and met-enkephalin, which excluded Triton-X. Antigens were
visualized with Alexa-488 or Alexa-546 secondary antibodies
(1:1000, Molecular Probes, Carlsbad, CA, USA), or biotinylated sec-
ondary antibodies(Vector, Burlingame, CA,USA)processedby ABC
histochemical method (Hsu et al., 1981) and developed with 3,30-
diaminobenzidine. Control sections were processed with omission
of primary antisera. Nissl substance was stained by Cresyl violet.
Timm staining to label zinc in mossy ﬁbre synaptic vesicles and
evaluate mossy ﬁbre sprouting was performed on a separate
group of BD animals 6 weeks after infection and age-matched NL
uninfected animals according to the procedure of Vaidya et al.
(1999). Brightﬁeld and ﬂuorescence signals were detected with
a Nikon E800 epiﬂuorescence microscope equipped with Spot2
CCD Digital Camera and Spot and Spot Advanced imaging soft-
ware. Photomicrograph images were transferred into Photoshop and
assembled using Adobe Photoshop CS.
BrdU quantiﬁcation
Sections of 50 mm thickness were collected on a freezing microtome
through the entire rostrocaudal hippocampal formation with every
sixthsectionslidemountedforBrdUcounting.Slideswereexamined
forBrdU-positivecellsinthegranulecelllayerofdentategyrus.BrdU
positive cells within the subgranular zone that were within 2-cell
body widths of the granule cell layer were considered part of the
granule cell layer (Kuhn et al., 1996). All BrdU-positive cells within
the granule cell layer, regardless of size or shape, were counted under
·400 magniﬁcation throughout the rostral-caudal extentof the gran-
ule cell layer. Total numbers of BrdU-stained cells in the granule cell
layer were multiplied by six and reported as total numbers of cells
in the granule layer. Raw data for cell counts were statistically ana-
lysed using Student’s t-tests (P < 0.05). To control for differences
in bioavailability or cell uptake of BrdU between uninfected and BD
rats, BrdU-labelled cells in corpus callosum were counted in selected
sections of age-matched NL and BD rats. The subventricular pro-
liferative zone was not used as a control because animals were
infected by intracerebroventricular (ICV) inoculation.
Analysis of phenotype
Aone-in-sixseriesofsectionsfromcontrolandBDanimalssurviving
1 day, 1 week, 4 weeks after injection of BrdU were double-labelled
forNeuN,GFAP,BDV,OX42,dynorphinAormet-enkephalinusing
ﬂuorescent methods. At least 25 BrdU cells in the granule cell layer
per rat were examined for colocalization and analysed using Spot
Advanced Image Analysis or Bio-Rad MRC-600 laser confocal
microscope.PercentagesofcolabelledBrdU-positivecellsweredeter-
mined by manual counts of digitally recorded images. Differences in
treatment groups, set in 2 · 2 tables, were assessed by Chi-square
analysis.
Other chemistries
Host soluble factors with regulatory actions on neurogenesis or
dynorphin were assessed.
Coticosterone levels
Circulating corticosterone fromwholebloodcollectedat6p.m.from
BD rats 6 weeks after infection and age-matched controls, were
assayed by radioimmunoassay (ICN-rat corticosterone Immuno-
chem Double Antibody 125I RIA kit, Linco Diagnostic Services,
St Louis, MO, USA) with the sensitivity or detection limit approxi-
mately 5.7 ng/ml. Duplicate samples were analysed and expressed as
ng/ml. Group differences were analysed by Student’s t-tests with
signiﬁcance set at P < 0.05 (n = 8–10 per experimental group).
BDNF (brain-derived neurotrophic factor)
analyses
BD rats from separate groups of animals, 6 weeks after infection
and age-matched controls, were euthanized by inhaled methoxy-
ﬂuorane, administered in a closed bell jar containing gauze soaked
with anaesthetic to achieve 0.22% minimal alveolar concentration,
followed by decapitation. Brains were rapidly removed, cut into
coronal sections by razor blades using an ice-cold aluminium
alloy mould, and the entire hippocampal formation (dentate
gyrus and CA regions) dissected from these sections. Tissue was
manually homogenized in lysis buffer (137 mM NaCl, 20 mM
Tris, 10% glycerol, 1 mM PMSF, 10 mg/ml aprotinin, 1 mg/ml
leupeptin, 0.5 mM Na vanadate, 1% NP-40), as described
(Lauterborn et al., 2000). Total BDNF protein content for each
sample was measured using the BDNF Emax Immunassay System
(Promega, Madison, WI, USA) with absorbance at 450 nm deter-
mined using a plate reader. Data analysis—differences between BD
and NL groups in BDNF were analysed by Student’s t-tests with
signiﬁcance set at P < 0.05 (n = 8 per group).
644 Brain (2006), 129, 642–654 M. V. Solbrig et al.
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 Results
Seizures in BD rats
ICV infection of 4-week-old periadolescent Lewis rats is an
established model of encephalitis (Narayan et al., 1983). To
assess effects ofinfectiononelectroencephalographictracings,
serial EEGs of BD rats were recorded over the course of infec-
tioninfreelymovingratsfromscrewelectrodesoverlayingthe
hippocampus. After 3 weeks of infection, the earliest EEG
changes were frequent sharp waves. Disorganized EEG pat-
terns, with complex polyphasic waves containing an admix-
tureoffrequencies,wereobtained4weeksafterinfectionfrom
BD rats showing startle myoclonus and hyperactivity. More
encephalopathic EEGs with burst suppression patterns—high
voltage bursts of slow waves intermingled with sharp transi-
ents or spikes against depressed background—were obtained
6 weeks after infection from BD rats showing stereotypical
behaviours, rearing, falling or wild running. Furthermore,
within another 2–4 weeks, repetitive sharp waves on EEG
were captured, time-locked to spontaneous seizures as
periods of behavioural arrest, staring spells, automatisms
such as lip smacking, blinking, head nodding or retrocollis
(dorsal head and neck extensions), falls or clonic limb move-
ments (Fig. 1 lower tracings). Epileptiform activity was not
observed in NL uninfected rats (Fig. 1 upper tracings).
A kappa opioid blocks seizures
The general opiate antagonist NLX is a dose-dependent con-
vulsant in BD rats (Solbrig et al., 1996), producing periodic
sharp waves on hippocampal EEGs together with staring
spells, behaviour arrest, eye blinks or clonic movements,
and c-fos elevations in hippocampus and amygdala (Solbrig
et al., 2005). To further evaluate a role for opioids in brain
excitability,theeffectofakappaopioidonseizuresinducedby
naloxone was examined. NLX (1 mg/kg s.c.) rapidly and con-
sistently caused seizures with a transition from background
Fig. 1 Spontaneous epileptiform activity in BD rats. Representative EEGs recorded from hippocampal leads from NL uninfected rats (top)
and BD rats (middle and lower tracings) during the course of infection (animal ages 7, 8, 10 and 12 weeks). Baseline activity from freely
moving NL rats characterized by low amplitude desynchronized activity have little variation, in contrast to progression from increased
sharp waves (7 weeks), to complex polyphasic waves (8 weeks) and high amplitude bursts (10 weeks) in BD rats during the course of
infection. A spontaneous seizure with myoclonus occurs when background burst activity transitions to continuous spike or sharp
wave discharges (BD rat, 12 weeks).
Kappa opioid control of viral seizures Brain (2006), 129, 642–654 645
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
3
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 646 Brain (2006), 129, 642–654 M. V. Solbrig et al.
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
3
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 burst activity to rhythmic spike or sharp wave discharges
within 5 min of drug administration (Fig. 2A). Administra-
tion of the selective KOR agonist U-50488 (40 mg/kg s.c.)
10 min before NLX (1 mg/kg s.c.) prevented NLX-induced
seizures in all BD rats tested (BD NLX 8/8 seizures versus BD
U50488 + NLX 0/8 seizures; 2I ˆ = 22.18 df = 1, P < 0.001, n = 8
per group) (Fig. 2A, lower tracing). Breakthrough seizures, as
isolated EEG spikes and runs of sharp waves were recorded
from BD animals receiving lower doses of U-50488 (10 and
20 mg/kg s.c.) (not pictured).
To conﬁrm a role of kappa opioids in protecting the
brain from overstimulation, behavioural effects of the kappa
opioid antagonist nor-BNI were examined. Administration of
the KOR antagonist nor-BNI (10 mg/kg s.c.) had convulsant
effects, producing recurrent hippocampal spike or sharp wave
discharges accompanied by staring spells, lip trembling
or smacking, rhythmic trunk ﬂexions or hindlimb extensor
spasms. Ictal episodes occurred 45 min to 2 h after drug
administration (BD nor-BNI 7/7 seizures versus NL
nor-BNI 0/4 seizures; 2I ˆ = 9.87, df = 1, P < 0.01, n = 4–7
per group), consistent with the peak KOR blocking effect
(Endoh et al., 1992) (Fig. 2B).
To evaluate a mu opioid receptor component to the sei-
zures, BD rat behaviours were probed using the mu opioid
receptor agonist morphine. Morphine (5 mg/kg s.c.) induced
epileptic behaviours:staringspells ormyoclonic jerksof trunk
or forepaws time-locked to periodic spike or wave discharges
on EEG (BD morphine 5/5 seizures versus NL morphine
0/5 seizures 2I ˆ = 13.86, df = 1, P < 0.001, n = 5 per group).
Ictalepisodes,beginning15–20minafterdrugadministration,
were frequent at 30 min (Fig. 2C), approximating the kinetics
of binding and receptor-induced internalization of opioids
with their receptors in mammalian cells (Gaudriault et al.,
1997).
SpeciﬁcityoftheKORsystem foranticonvulsanteffectswas
assessed by U-50488 treatment prior to morphine. Adminis-
trationof the KORagonist U-50488 (40 mg/kg s.c.) toBD rats
10 min before morphine (5 mg/kg s.c.) prevented seizures in
all rats tested (BD U50488 + morphine 0/5 seizures versus
BD morphine 8/8 seizures, 2I ˆ = 17.32, df = 1, P < 0.001,
n = 5–8 per group), but the KOR agonist-morphine combi-
nation depressed both consciousness and EEG tracings
(Fig. 2C, lower tracing).
Encephalitis induces dynorphin
loss in hippocampus
To assess neuropathological effects, BD rat brains were
examined. BD rats 6 weeks after infection showed an
atrophic, disorganized hippocampal formation with laminar
disruption and apparent increased density of cells in
hilus (Fig. 3A). The granule layer was preserved as a rim of
NeuN-positive cells (Fig. 3B). A proportion of surviving
neurons were BDV positive, recognized by BD nucleoprotein
antibody (Fig. 3A, top right).
Coincident with granule cell loss, mossy ﬁbre labelling was
not seen inBD rats. Timm staining wasattenuated in thehilus
and granule cell layer, and absent from the molecular layer
(Fig. 3C). In Fig. 3D and E, neither dynorphin nor enkephalin
labelling in cell bodies is discernible in BD rats.
Encephalitis induces enkephalin
increase in CA1
In contrast to the dentate gyrus, met-enkephalin immuno-
staining was faint in cell bodies that were sparsely scattered
in stratum radiatum of hippocampal ﬁeld CA1 of NL rats
(Fig. 3F) but prominent in CA1 interneurons of BD rats
(Fig. 3F arrows). Cell bodies labelled in CA1 were: (regio
superior and inferior) stratum pyramidale cells that extend
apical dendrites into stratum radiatum of hippocampal ﬁeld
CA1, stellate and bipolar stratum radiatum neurons with
a dendritic process radiating to pyramidal layer and another
to hippocampal ﬁssure. The cells correspond in localization
and morphology with previously described populations of
enkephalin-like immunoreactive interneurons of the stra-
tum pyramidale, stratum radiatum, and stratum radiatum–
stratum lacunosum-moleculare interface (Gall et al., 1981).
BD rat met-enkephalin-like IR cells also immunostained with
BDV nucleoprotein antibody (Fig. 3F, right).
Failed neurogenesis and survival of
new neurons contribute to dynorphin
loss in hippocampal formation
To study the developmental aspect of dynorphin expression
in hippocampal formation, the development and maturation
of granule cells, the only dynorphin-expressing cells of the
Fig. 2 Pharmacological analysis of epileptic phenotype with EEG recordings from hippocampal leads from freely moving BD and NL rats.
(A) In BD rats, NLX (1 mg/kg s.c.) administration elicits rhythmic (2 per second) high amplitude spike or sharp wave discharges and
displays of behaviour arrest, blinks or head nods. This seizure, recorded 15 min after drug administration, is typical of patterns recorded
from 5–45 min after NLX. U-50488 treated animals have no seizures. Pretreatment with the selective KOR agonist U-50488 (40 mg/kg s.c.)
before a single dose of NLX (1 mg/kg s.c.), prevents clinical and electrographic seizures (n = 8 per group). In NL animals, NLX
administration elicits increased numbers of sharp waves, but no seizures. U-50488 and U-50488-NLX treated NL animals have no
epileptiform activity (n = 8 per group) Representative EEGs recorded 15 min after drug administration are shown in A.( B) In BD rats,
nor-BNI (10 mg/kg s.c.) administration elicits rhythmic sharp wave discharges and synchronous clonic trunk movements in the 45–120 min
interval after drug administration. Nor-BNI treated NL animals have no seizures (n = 4–7 per group). Representative EEGs recorded 45 min
after drug administration are shown in B.( C) In BD rats, morphine (5 mg/kg s.c.) administration elicits seizures: staring spells and blinks
time locked to rhythmic sharp wave discharges recorded 15–45 min after morphine. Pretreatment with U-50488 (40 mg/kg s.c.) before a
single dose of morphine (5 mg/kg s.c.) prevents clinical and electrographic seizures. In NL animals, morphine elicits increased EEG activity,
but morphine- and U-50488-morphine-treated NL animals have no seizures (n = 5–8 per group). Representative EEGs recorded
30 min after drug administration are shown in C.( D) EEGs of vehicle-treated animals are shown for comparison.
Kappa opioid control of viral seizures Brain (2006), 129, 642–654 647
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 hippocampalformation(McGintyetal.,1983)wereexamined
following injections of BrdU (50 mg/kg i.p. ·3) on day 7
of infection. BD and control rats were given BrdU to label
dividing cells and sacriﬁced at selected time points to track
proliferating cells. Differences in numbers and distribution of
proliferating cells were apparent at all time points. BD rats
showed fewer BrdU-positive cells in the granule cell layer
at 1 day (BD 6974 6 330 versus NL 12511 6 672, P <
648 Brain (2006), 129, 642–654 M. V. Solbrig et al.
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 0.01) as well as fewer BrdU-positive cells at all survival times
following BrdU injection (at 1 week BD 4282 6 332 versus
NL 7774 6 1099, P < 0.05; at 2.5 weeks, BD 1657 6 482 versus
NL38926370,P<0.05;at4weeks,BD13566105versusNL
3719 6 279, P < 0.01) (Fig. 4A).
Granule proliferative layers were disrupted or displaced by
neovascular areas, concentric circular areas of BrdU positive
cells along the subgranular zone (Fig. 4B, arrow). Diffuse
background staining seen at 2.5 and 4 weeks was attributed
to increased blood brain barrier permeability and penetration
of brain parenchyma by non-speciﬁc IgGs (Fig. 4B). There
were no apparent differences in bioavailability or cell uptake
of BrdU between uninfected and BD rats. BrdU-labelled cell
counts in corpus callosum did not differ across groups at
early survival times (data not shown).
Next, viral effects on new neuron survival were character-
ized. To track cell phenotypes present in the BrdU-labelled
cell population of the granular zone, sections were immuno-
stained for cell markers. Proportions of each indicated
phenotype were calculated in marker/BrdU double-positive
cells (Fig. 4C). Quantiﬁcationof NeuN, BrdUdouble-positive
cells showed that NeuN was expressed in 82% of BrdU cells
in NL rats and that NeuN was expressed in 47% of BrdU
cells of BD rats at Day 1. With NeuN-labelled cells account-
ing for only 9% of the surviving BrdU cells in BD rats at
4 weeks versus 86% in NL controls, levels of NeuN/BrdU
cells after 4 weeks were signiﬁcantly lower in BD rats (x
2 =
19.795, P < 0.0001). At the later, 4-week time point, BrdU
cells were perivascular, not neural, and not recognized by
BDV antibody. Thus, BD animals lost more new neurons
than controls. BrdU cells showed neither dynorphin A IR,
a marker for mature granule cells, nor met-enkephalin IR.
Microglia became the predominant new cell type. A total of
82% of BrdU-positive cells co-label with the microglial
marker OX42 at the 4-week time point (Fig. 4C), and
OX42-stained cells ﬂood the dentate gyrus and perivascular
areas (Fig. 4D).
BDV is an infection of CNS neurons and glia (Gosztonyi
and Ludwig, 1995) and successfully establishes infection
in neonatal, young and mature rodent brains. This is reﬂected
in BrdU + proliferating cells being co-labelled by BDV
antibody early in infection in our model. To begin to char-
acterize the early neural lineage cells that are recognized
and infected by BDV, double IHC was performed using
antibodies to BDV and Mash-1, a beta helix-loop-helix
transcription factor expressed in neuronal progenitors
(Ross et al., 2003). Proliferating cells committed to a neural
fate were infected and expressed BDV nucleoprotein one
week after infection (Fig. 5B). However, later in infection,
neuroblasts or DCX positive cells (Gleeson et al., 1999;
Brown et al., 2003) could not be recognized (Fig. 5D). Clearly,
BDV infection is damaging to developing neurons. At which
stage virus is toxic to developing neurons will be the subject
of further study.
To study actual dynorphin expression in hippocampal for-
mation, the effect of BDV infection on dynorphin mRNA in
hippocampal formation was examined by northern blotting.
PPD transcripts in BD rat hippocampus were decreased but
not absent (BD 1165 6 800 versus NL 15255 + 1037, mean
optical density, arbitrary units, t(1,14) = 10.749, P < 0.0001,
n = 8 per group). Low corticosterone (Thai et al., 1992) or
elevated BDNF (Croll et al., 1994) can downregulate dynor-
phin at the level of transcription. To examine whether host
soluble factors could be linked to decreased transcription or
stability of a dynorphin precursor mRNA in surviving dentate
granule cells, serum corticosterone and hippocampal BDNF
levels were measured. No group differences in BDNF levels in
hippocampal formation were observed [BD 1.064 6 0.122
versus NL 1.011 6 0.125 pg/100 mg, t(1,15) = 0.299, P =
0.7689 n = 8–9 per group]. Corticosterone levels were not
reduced, but instead were increased in BD rats [BD 282.00 6
30.027 versus NL 212.20 6 11.563 ng/ml, t(1,16) = 2.354,
P < 0.05, n = 8–10 per group], to suggest a host role in
inhibition of neurogenesis (Cameron and Gould, 1994).
Discussion
The present study supports the hypothesis of a critical role of
opioids in the maintenance of a balanced tone of activity
in hippocampal circuits related to seizure induction, and a
key role for the KOR in anticonvulsant protection in viral
seizures in rodents. Our results show a rodent model of
viral encephalitis based on BDV reproduces a functional
neurochemical change, low dynorphin tone, important in
epilepsy vulnerability. Genotypes producing low dynorphin
tone are associated with temporal lobe epilepsy and febrile
seizures in man (Stogmann et al., 2002; Gambardella et al.,
2003). BD rats lack hippocampal dynorphin owing to
Fig. 3 Viral-induced opioid pathology in coronal sections through hippocampus. (A) Nissl-stained sections show contraction of
hippocampus with laminar disruption and nerve cell loss in BD rats. Some dentate granule cells are labelled by BDV antibody (arrow,
top right). (B) Robust NeuN IR in dentate layers, hilus and CA3 in NL rats contrasts with residual granule layer preserved as rim of
NeuN-positive cells in BD rat (right). (C) Higher magniﬁcation shows Timm staining of hilus, portions of granule cell layer and
molecular layer near tip of dentate gyrus in NL rats. Such staining is attenuated in BD rats, and absent from supragranular regions
(right). (D) A network of dynorphin A-like IR cells and the processes of granule cells are visible in the NL rat but absent in the BD rat.
(E) The overlapping dentate network of met-enkephalin-like IR cells and processes in the NL rat is reduced in the BD rat to scattered
IR particles through granule and subgranule layers. (F) In CA1, met-enkephalin-like IR interneurons are faint in NL rat, but they are
much more intensely stained in the BD rat (arrows). Met-enkephalin-like IR cells also expressed BDV nucleoprotein antigen (arrows).
Scale bars = 200 mm( A, B and F: photographed at 100·; C, D and E: photographed at 200·). NL, normal uninfected, BD, Borna disease
rat, g, granule cell, hf, hippocampal ﬁssure, aBD, anti-BD, BDV nucleoprotein antibody.
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 depopulation of the granule layer and loss of competence of
surviving granule cells to express dynorphin. Mechanisms of
dentate gyrus dynorphin depletion as well as upregulation of
enkephalin elsewhere in the hippocampus are demonstrated.
The non-selective opioid receptor antagonist NLX has
been shown to produce seizures in BD rats which map to
hippocampal and limbic circuits (Solbrig et al., 1996, 2005).
Their seizures have a periodicity of 1–2 per second, within
the dynamic range for frequency-dependent facilitation of
hippocampus (Nadler, 2003). In this study, administration
ofthekappaagonistU-50488controlsNLXseizures,whilethe
selective kappa antagonist nor-BNI reproduces the convulsive
phenotype. NLX seizures, with latencies of <5 min, were
distinct from morphine seizures, with onsets 15–20 min
after drug administration, and were frequent at 30 min,
matching the internalization kinetics of binding and
receptor-induced internalization of opioids with their
receptors (Gaudriault et al., 1997).
Speciﬁcity of kappa effect also is supported by the ﬁnding
that the kappa agonist U-50488 blocks convulsant effects of
morphine (5 mg/kg s.c.) in BD rats. The results suggest that
a resting, non-seizing hippocampus requires balanced kappa
and mu opioid tone. Once endogenous opioid systems are
destabilized, seizures result.
A role for hippocampal opioid systems in seizure vulner-
ability is in agreement with previous studies of animal
models of seizure risk following in utero morphine exposure
(Schindler et al., 2004). In male rats prenatally exposed to
morphine, epileptiform activity is more easily induced in
entorhinal cortex (Velisek et al., 2000) and systemic naloxone
increasesseizuresusceptibility(Schindleretal.,2004).Inutero
morphine exposure reduces dynorphin-derived peptides in
CA3 and increases mu opioid receptors in dentate gyrus,
CA3, CA1 in adult male rats, as well as decreasing pro-
enkephalin mRNA/met-enkephalin peptide and increasing
prodynorphin mRNA/dynorphin B peptide in granule
layer of dentate gyrus. Naloxone seizures, measured as
decreased latency to bicuculline seizures after naloxone
administration, are associated with reduction in dynorphin
peptides in CA3 in these animals (Schindler et al.,2004).After
prenatal morphine exposure, ovariectomy and hormone
replacement, female adult rats have similarly increased
MOR binding in CA3 and increased susceptibility to ﬂurothyl
seizures (Slamberova et al., 2003).
In our model, NLX is convulsant by blocking KOR tone
from an already weakened or attenuated dynorphin system,
and morphine is convulsant by enhancing mu over kappa
tone. However, one cannot exclude convergent down-
stream or ion channel responses to NLX and morphine as
explanation for similarities in convulsant effects.
The chemical neuroanatomy of BD rat hippocampus is
consistent with the neuropharmacological results. Dynorphin
IR was absent in the dentate granule layer, and enkephalin IR
increased in CA1 of BD rats. Owing to retention of a dentate
layer of NeuN positive cells, loss of mature granule cells can-
not fully account for dynorphin loss. BrdU studies revealed
that the virus interfered with granule cell development and
survival, such that young neurons were lost too early to repo-
pulate the granule layer with mature dynorphin-positive
phenotypes. The dentate granule layer was sporadically
infected, thus limiting the direct role of virus in transmitter
downregulation (Hans et al., 2001). Hippocampal BDNF
levels were unchanged in BD rats and serum corticosterone
levels were increased, and such changes have not been
reported to downregulate dynorphin (Thai et al., 1992;
Croll et al., 1994). Effects at gene-expression level are not
excluded, but direct causes through viral interference or
host soluble factors were not found. However, BD rats show
early EEGs with high levels of bursting waves, and seizures
have been shown to deplete hippocampal dynorphin at the
mRNA and peptide levels (Xie et al., 1989; Douglass et al.,
1991, reviewed in Simonato and Romualdi, 1996). Thus, a
different host factor, subclinical seizures, could exhaust
dynorphin from surviving granule cells, triggering an evolu-
tion to clinical seizures. These results add to previous studies
of viral and immunological determinants of virulence, which
have already demonstrated depopulation of the granule layer
resulting from inﬂammatory/immune-based neuronal loss
(Gosztonyi and Ludwig, 1995; Planz and Stitz, 1999). The
chief damaging elements are cell loss, failure of neurogenesis,
depletion of dynorphin with seizures and inability to restore
dynorphin to meet demand. No doubt cell loss is important,
but it is multiple factors, acting together, that expose key
sites of vulnerability in the brain’s carefully regulated control
of excitability. Onecouldspeculatebased on thepresentstudy
that a signiﬁcant contribution to overall dynorphin pathology
is depletion of dynorphin with seizures.
The classic hippocampal circuit is a trisynaptic circuit
utilizing glutamatergic neurotransmission. At each step,
excitatory tone is modulated by a diverse group of inhibitory
and excitatory neurons (Freund and Buzsaki, 1996). In
normal brain, the dentate granule cells serve as a high-
resistance gate or ﬁlter, inhibiting propagation of hypersyn-
chronous discharges from entorhinal cortex to hippocampus.
Gating depends on several factors, including release of
inhibitory neurotransmitters, such as dynorphin and others,
and structural integrity. BDV-induced loss of the neuro-
pharmacological and structural gate, as shown in this study
by failed neurogenesis and infection of young neurons,
may prove important in initiation and spread of temporal
lobe seizures. Dynorphin or kappa opioid presynaptic
inhibitory effects in hippocampus through Shaker type potas-
sium channels on mossy ﬁbres (Simmons and Chavkin, 1996)
are presumed lost to the BD rats. However, dynorphin also
decreases neuronal activity via post-synaptic actions on
potassium M channels of principal CA3 and CA1 hippo-
campal neurons (Moore et al., 1994; Madamba et al.,
1999). It is the anticonvulsant actions of KOR agonists on
CA3 or CA1 principal neurons, neurons that survive in
BD viral infection, that mediate the pharmacological
effects observed in this study, which may be considered
therapeutically relevant.
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 Fig. 4 Viral effects on neurogenesis, survival and phenotype. (A) Numbers of BrdU-labelled cells in granule layer of hippocampus at
various time points after BrdU injection. BDV infection decreases numbers of BrdU labelled cells within granule cell layer and subgranule
zone 1 day, 1, 2.5 and 4 weeks after BrdU injection, relative to normal uninfected rats. *P < 0.05, **P < 0.01 values are mean (6 SEM)
cell counts per animal for entire hippocampus (n = 4 per group for each time point). (B) Distribution of BrdU-labelled cells. Coronal
sections through the hippocampus of NL and BD rats show proliferating cells stained by antibodies against BrdU at 1 day, 1, 2.5 and 4 weeks
after BrdU injection. Arrow indicates area of inﬂammatory angiogenesis interrupting granule layer proliferation in BD rat. (C) Percentage of
BrdU positive cells that colabelled with NeuN, GFAP, BDV antibody or OX42, measures neurons, glia, infected cells and microglia,
respectively, among proliferating cells. During BD, there is a progression of BrdU-positive phenotypes, from NeuN and GFAP early
in disease, to OX42 late in disease. Roughly 50% of BrdU-labelled cells are NeuN-positive at day 1, 82% of BrdU cells are OX42
immunoreactive at 4 weeks. BrdU-labelled cells were scored within granule cell layer and subgranule zone. NeuN, neuronal nuclei, GFAP,
glial ﬁbrillary acidic protein, OX42, monocyte microglia marker. (D) OX42 immunoﬂuorescence staining shows the microglial response to
BD infection 4 weeks after BrdU injection. The dentate gyrus, hilus, ﬁssure and perivascular areas of BD rat hippocampus are heavily stained
(lower panel) compared with NL rat hippocampus. Scale bars = 200 mm.
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 Beyond the dentate gate, interneurons showing increased
enkephalin IR, which co-localized with BDV IR in inter-
neurons of stratum radiatum and stratum pyramidale
of CA1, are positioned to inﬂuence mu receptors over a
wide distribution and strengthen hippocampal excitation.
In rodents, mu opioid receptors are on a neurochemically
heterogeneous subset of hippocampal interneurons, most
frequently on interneurons that are specialized to inhibit
pyramidal cells (Blasco-Ibanez et al., 1998). In this distri-
bution, interneurons use mu opioids to limit their own
activity as well as that of their targets (Drake and Milner,
2002; Drake et al., 2002). Thus, there is a net excitation,
either by enkephalin upregulation arising as a direct effect
of virus (Solbrig et al., 2002), or by overstimulation of
stratum radiatum interneurons. Prominent enkephalin stain-
ing in BD rats may signify recurrent seizures, with CA1
enkephalin interneurons activated in feedforward manner
by Schaffer collaterals, using the hippocampal intrinsic
excitatory circuit of CA3 projections to CA1. Prominent
enkephalin staining may also signify more interconnected
networks, with reorganization of CA1 associational pathways
intomoreexcitatorynetworks(Esclapezetal.,1999;Lehmann
et al., 2001).
Thus, viral infection, by producing opioid system
destabilizations, induces the same limbic opioid changes as
would be anticipated during frequent hippocampal seizures
(i.e. dentate dynorphin depletion by perforant path activity
and CA1 enkephalin interneuron stimulation by feedforward
Schaffer collateral excitatory activity). These opioid changes
promote and sustain a proconvulsive state. The Borna model
illustrates circumstances that deplete dynorphin from the
granule cell layer and upregulate enkephalin elsewhere in
the hippocampus. The BD rat overlaps with other epilepsy
models with dynamic neuropeptide proﬁles that have estab-
lished a role of dynorphin deﬁcits in seizures. However, the
BD model goes on to demarcate an increased, excitatory
enkephalin network in CA1 and supports an additional
role for CA1 enkephalin upregulation in seizure vulnerability.
The model may apply to any condition with granule cell loss,
silencing or failed neurogenesis and enhancement or redirec-
tion of excitation to CA1. Thus, the model may generalize to
other epilepsies where dynorphin depletion due to recurrent
seizures and enkephalin upregulation in CA1 interneurons
due to repetitive hippocampal circuit stimulation occurs.
The epileptic syndrome produced by the BD rat is greatly
simpliﬁed at the neuropharmacological level by the observa-
tion that restoration of dynorphin tone can prevent seizures.
Normally, KOR receptors are found on mossy ﬁbre terminals,
principal neurons, perforant pathway and supramamillary
afferents (reviewed in Solbrig and Koob, 2004). The dynor-
phin system, hypothesized to be a neuromodulatory homeo-
staticsystem,may bereleasedondemand byexcessivestimuli.
KOR activation in hippocampus achieves effects desirable
in anticonvulsants. The KOR effects include opening K+
channels (Simmons and Chavkin, 1996) or closing Ca2+
channels (Rusin et al., 1997), thereby controlling pre-synaptic
transmitter release, increasing M type K+ currents to stabilize
membranes and post-synaptically silence excitatory neuro-
transmission (Madamba et al., 1999), or acting on classes
of interneurons (Racz and Halasy, 2002) to desynchronize
the gamma aminobutyric acid inhibitory network. Due to
preservation of some of these actions in BD rats, a single
pharmacological manipulation, the use of a drug with narrow
(KOR)speciﬁcity,appearstoovercomethemixofneurophar-
macological and lesion effects produced in BD rats.
A dominant role for dynorphin, trumping other trans-
mitters, in defending against encephalitic seizures, may be
an important part of the normal neuroadaptive response
of the brain to overstimulation. A more radical view pos-
sibly important for the pathogenesis of seizures is that the
phenotype is determined by the most prevalent break
with homeostasis, which in this case is by dynorphin, an
inhibitory/modulatory neurotransmitter, and such a view
suggests the feasibility of exploring the use of kappa opioid
agonists in refractory seizures.
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